Companion Animals

CatsDogs
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Schering-Plough Corporation, its subsidiaries or related companies. As used in this publication, the terms “Schering-Plough” and the “company” refer collectively to Schering-Plough Corporation, the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

What's New?

Small Animal Vaccines

Active immunization against canine diseases. Key products in this range are Nobivac DHP, Nobivac DHPPi, Nobivac Lepto, Nobivac KC and Nobivac Rabies.


Scalibor® Protector Band

A long acting antiparasitic for dogs against sand flies, ticks and mosquitoes. The band is formulated according to patented technology that enables slow release of deltamethrin, the active ingredient, directly onto the skin.


DateDescription
23 June 2010Deltamethrin-impregnated collar provides a cost-effective solution to control canine and human LeishmaniasisBOXMEER (The Netherlands) June 23, 2010 - Delegates at the 2nd International Congress on Canine Leishmaniasis, which was recently held in the Italian city of Pisa, heard how a readily-available deltamethrin-impregnated ...
25 November 2009Carbimazole (VIDALTA) treatment in cats with hyperthyroidism normalizes thyroid hormone levels and improves clinical signsBOXMEER (the Netherlands), November 25, 2009 — Treatment of hyperthyroidism in cats with VIDALTA® - a novel, once-daily oral formulation of carbimazole - reduces thyroid hormone concentrations, bringing ...
2 November 2009Schering-Plough announces sponsorship of rabies-control project in IndiaKENILWORTH, N.J., Nov. 2, 2009 – Schering-Plough Corporation (NYSE: SGP) today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through ...
23 June 2009Vaccine Against Canine Flu Granted Conditional License by USDAROSELAND, N.J., June 23, 2009 – Intervet/Schering-Plough Animal Health, the global leader in veterinary biologicals, today announced the availability of the first vaccine against canine influenza virus ...
17 June 2009Intervet/Schering-Plough Animal Health introduces NOBIVAC Lyme, a unique vaccine providing dogs with dual protectionROSELAND, N.J., June 15, 2009 – Intervet/Schering-Plough Animal Health announced the introduction of NOBIVAC Lyme. This new-generation Lyme vaccine is the only vaccine specifically designed to provide ...
4 June 2009Intervet/Schering-Plough Animal Health continues to support the Afya Serengeti rabies project - Children join the fight to eradicate rabiesBOXMEER (The Netherlands), June 4, 2009 - Eradication of rabies remains firmly on the agenda for Intervet/Schering-Plough Animal Health as the company launches its latest campaign to support the Afya ...
9 October 2008Intervet/Schering-Plough Animal Health extends its portfolio with LEVENTA® and supports veterinary endocrinologyBOXMEER (the Netherlands), October 9, 2008 – As the global leader in the field of veterinary endocrinology, Intervet/Schering-Plough Animal Health today announces a further extension to its portfolio ...
20 August 2008Intervet/Schering-Plough Animal Health shows innovative portfolio at WSAVA congress, Dublin - Hubert Trentesaux appointed as head of Global Companion AnimalBOXMEER (the Netherlands), August 20, 2008 – At the 33rd annual World Small Animal Veterinary Association Congress (WSAVA)  in Dublin, Ireland, August 20-24, Intervet/Schering-Plough Animal Health, presents ...
27 February 2008Intervet takes the lead in veterinary endocrinology at NAVCORLANDO, FL, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ...
19 January 2008Schering-Plough & Intervet together for better careORLANDO, FL, January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer health customer ...
15 January 2007Intervet organizes two international symposia at NAVCOrlando, January 15, 2007 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet organized two international symposia at ...
15 June 2006Free vaccine support for assistance dogsAssistance dogs fulfil a valuable role in society, greatly improving the quality of life enjoyed by their owners. Maintaining the health of these animals is crucial, but imposes additional financial burdens ...
15 December 2005Reducing animal testingClostridial bacteria produce toxins that cause a range of diseases in animals.  Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ...
22 September 2005Schering-Plough Animal Health Lends Aid and Support to People and Pets Affected by HurricaneKatrina Disaster Underscores Importance of Animal IdentificationSchering-Plough Animal Health Corp. (SPAH) today announced that it has contributed nearly $130,000 to aid Hurricane Katrina relief efforts ...
15 September 2005Intervet facilitates development of global small animal vaccination strategyIn September 2005, Intervet International organized the international symposium Canine and Feline vaccination – A scientific re-appraisal, in conjunction with the University of Utrecht’s Faculty of Veterinary ...
25 June 2005Forging the Link campaign - Intervet UKIt is becoming increasingly recognized that family pets are being used as a tool to manipulate and control victims of domestic violence. Dad threatening to drown the kitten if little Tommy does not let ...
25 June 2005Afya Serengeti project - Intervet UK‘Afya Serengeti’ means ‘Health for Serengeti’ in SwahiliHelping to control the incidence of animal and human rabies in north-western Tanzania is a key focus for Intervet UK this year and as such, the ...